Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole fMRI Study in Autism Spectrum Disorders
NCT01028820Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Aug 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in Autism Spectrum Disorder (ASD), sponsored by University of North Carolina at Chapel Hill. Started Aug 2009; status: completed.
02
Drugs
aripiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01028820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01028820.